In order to help physicians to systematically learn and apply immunotherapy, understand the frontier and progress of immunotherapy, and deal with the adverse reactions of immunotherapy, Chengdu High-tech Medical Association and Sichuan Yuntaijia Business Service Co., Ltd. jointly hosted the 2021 immunotherapy series of lectures and academic activities , Invite experts and professors from major centers in the field of immunotherapy to give lectures and participate in discussions on the latest developments in immunotherapy. On December 8, the first CAR talk talk lecture was successfully held online.

Professor Liu Ting of West China Hospital of Sichuan University and Professor Zhang Yicheng of Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology gave opening speeches and conclusions; Professor Li Chunrui of Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology emphasized on Efficacy Risk Monitoring and Follow-up Management; Professor Jin Zhengming from the First Affiliated Hospital of Soochow University shared and in-depth analysis of the "Analysis of Patient Types Using CART Cell Therapy"; Based on the questions and thoughts raised by online professors, Tongji, Huazhong University of Science and Technology Professor Xiao Yi from Tongji Hospital affiliated to the School of Medicine, Professor Jiang Ming from West China Hospital of Sichuan University, Professor Hong Huangming from Sichuan Cancer Hospital and all the guests had a heated topic discussion and in-depth discussion.

The birth of immunotherapy is currently regarded as the fourth largest cancer treatment after surgery, radiotherapy and chemotherapy, and targeted therapy, especially CART therapy. It has achieved breakthrough treatments in the field of hematological tumors, bringing it to patients with relapsed and refractory DLBCL Hope of cure. New technologies and new treatment methods can better ensure the safety of patients and bring greater benefits to patients through standardized clinical full-process management. This academic conference promoted the communication between the oncology community, through the exchanges, the integration of high-quality medical resources, the construction of communication bridges, and the strengthening of CART therapy lay a solid foundation.